An ErbB2 overexpressing transgenic mouse exhibits increased numbers of LPC-like cells in the liver [59], and increased expression of ErbB family members is reported in a high proportion of human HCCs and correlates with cancer progression [60]. Here, ERBB2 is linked to cancer.